iMTA BV

institute for Medical Technology Assessment (iMTA)

For over two decades already, the institute for Medical Technology Assessment (iMTA) has played a key role in MTA research in the Netherlands, in Europe and worldwide. The institute was founded in 1988, at the Erasmus University Rotterdam by Professor Frans Rutten. The iMTA is a university-based scientific institute that is distinguished by independent and excellent research in medical technology assessment, including health economics and health outcomes research. It is dedicated to support the use of cost-effectiveness information in healthcare decision making. To date, over 600 research projects have been completed in various areas of medicine. Major funding bodies like governments and government-related institutions, the European Commission, the WHO, health care organizations, charity foundations and the pharmaceutical industry, sponsored these projects.

MAIN ACTIVITIES OF THE iMTA

  • Conducting applied scientific research in economic evaluation and MTA
  • Making available the results of this applied research to support reimbursement decisions
  • Approving existing methods and developing new methods and techniques
  • Making available the results of this methodological research to improve science and the process of decision making in healthcare
  • Provide teaching and training in economic evaluation and MTA research
  • Undertaking consultancy for public authorities and commercial companies

iMTA’S MAIN PRODUCTS ARE

  • Cost-of-illness studies
  • Economic evaluation
  • Early-HTA
  • (Micro-)costing
  • Health status measurement
  • Patient-reported outcome
  • Preference measurement
  • Modeling
  • Simulation
  • Value of information analysis
  • Data-base research
  • Outcome research
  • Broad societal benefits
  • Meta-analysis
  • Patient-registries
  • Education
  • Consultancy

The iMTA offers excellent expertise in the core disciplines necessary to perform comprehensive MTA studies, including modeling, and it provides the infrastructure for carrying out prospective economic evaluation studies linked to clinical trials. Medical, economic, statistical and organizational expertise is available to meet all practical and scientific challenges of experimental research. The staff of the iMTA consists of about 30 scientists from different disciplines, including economics, medicine, health sciences, psychology, epidemiology, mathematics, pharmacy, and policy and organization. iMTA is closely linked to Erasmus School of Health Policy & Management (ESHPM), such that it can offer expertise that covers the broad area of health services research.

Directeur:
Prof. dr. C.A.Uyl - de Groot
E-mail: uyl@eshpm.eur.nl

Adjunct-directeur:
Dr. M.P.M. H. Rutten - van Mölken
E-mail: m.rutten@eshpm.eur.nl

telnr: 010 - 408 85 71
Kamernr: W J5 - 37
Website: www.imta.nl

Raad van Commissarissen:
Prof dr. F.F.H. Rutten, voorzitter
Prof. dr. W.B.F.Brouwer
drs. C.M. Taia Boneco